LOS BAÑOS, Laguna — In a world where art is often seen as an escape, the oil painting installation of Chelsa Josephine Roldan Diamos titled "Ano An Nadudulang Ha Imo?" (What Is Holding You Back?) ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Legend Biotech Corporation Sponsored ADR (LEGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Known as a “silent disease”, metabolic dysfunction-associated steatohepatitis (MASH) is affecting a growing number of people, with an expected 27 million cases in the United States by 2030. 1 ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Citing “recent challenges in the capital markets,” Houston said the biotech is rethinking spending to ensure its current cash reserves can take its programs to data milestones. Arvinas is ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Buckner was speaking last month at Life Science Innovation Northwest, Seattle’s marquee gathering of the biotech industry. Most years, the two-day conference sees scientists, investors and other ...

Scientists have long observed this unusual mode of respiration and harnessed it in biotechnology as something of a black box. Now, a Rice-led team has uncovered its mechanism—a breakthrough that ...

He co-founded a biotech company called Variant Bio that has cut revenue-sharing deals with more than 25 Indigenous groups around the world to use their genomes to discover new targets for drugs.